Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jun 08, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Apr 11, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 70,000 --
Apr 11, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 70,000 $1.06
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jan 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 350,000 --
Dec 08, 2006
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Dec 08, 2006
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 --
Sep 26, 2006
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Sep 26, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 --
Jul 14, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 670 $3.56
Jul 14, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 4,330 $3.55
Jun 28, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 2,000 $3.45
Jun 21, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 2,500 $3.64
Jun 14, 2006
Chief Scientific Officer
Chief Scientific Officer Open market or private purchase of non-derivative or derivative security 2,500 $3.75
Jun 12, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 3,000 $3.86
Apr 03, 2006
Chief Scientific Officer
Chief Scientific Officer Exercise of in-the-money or at-the-money derivative security 5,750 $3.00
Apr 03, 2006
Chief Scientific Officer
Chief Scientific Officer Exercise of in-the-money or at-the-money derivative security 5,750 --
Mar 31, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Open market or private purchase of non-derivative or derivative security 3,900 $4.69
Jan 01, 2006
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 80,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright West LLC. Minimum 15 minutes delayed.